Description
COVID-19 - ABBOTT ID NOW COVID TEST KITS
First action · last action
2021-12-27 · 2023-10-10
Transactions
4
First transaction's obligation
$3,990,800
Base + all options value (sum of deltas)
$14,999,040
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-12-27+$3,990,800= $3,990,800
- Mod P000012022-03-23+$11,008,240= $14,999,040
- Mod P000022022-06-16-$8,410,260= $6,588,780
- Mod P000032023-10-10-$250= $6,588,530
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-12-27 | +$3,990,800 | $3,990,800 | COVID-19 - ABBOTT ID NOW COVID TEST KITS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-03-23 | +$11,008,240 | $14,999,040 | COVID-19 - ABBOTT ID NOW COVID TEST KITS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-06-16 | −$8,410,260 | $6,588,780 | COVID-19 - ABBOTT ID NOW COVID TEST KITS |
| Mod P00003· FUNDING ONLY ACTION | 2023-10-10 | −$250 | $6,588,530 | COVID-19 - ABBOTT ID NOW COVID TEST KITS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI P782RNU1NNK3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0699 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $82,304 | FY2026 |
| 36C24426N0511 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2026 |
| 36C25526N0126 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $54,108 | FY2026 |
| 36C24126N0170 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $123,000 | FY2026 |
| 36C24226N0185 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24425N0741 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2025 |
Other recipients under 6515 from SAC FREDERICK (36C10X) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C10X26D0033 | L1 ENTERPRISES INCORPORATED | SAC FREDERICK (36C10X) | $0 | FY2026 |
| 36C10X26K0480 | CONCORDANCE HEALTHCARE SOLUTIONS LLC | SAC FREDERICK (36C10X) | $5,937,032 | FY2026 |
| 36C10X26K0479 | MEDLINE INDUSTRIES, LP | SAC FREDERICK (36C10X) | $87,012,307 | FY2026 |
| 36C10X26D0035 | SAMSUNG HME AMERICA, INC. | SAC FREDERICK (36C10X) | $0 | FY2026 |
| 36C10X26K0490 | AVMEDICAL LLC | SAC FREDERICK (36C10X) | $15,303 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C10X22P0015_3600_-NONE-_-NONE- · retrieved 2026-09-26.